DL
Insider
Darin Lippoldt
Chief Legal OfficerDarin Lippoldt (Chief Legal Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $1.8M of NBIX (10,000 sh × $179.60, as filed), executed Jul 9.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.2M
shares × price, as filed
Last traded
Jul 9
Filed Jul 13
Median ADV $194.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
NBIX
Neurocrine Biosciences, Inc.
NBIX · 0 buys · 6 sells
6 filings
Recent filings
NBIXSALE
Neurocrine Biosciences, Inc.
View filing →
$1.8M10,000 sh × $179.60
Exec Jul 9
Filed Jul 13 · 4:27 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $1.7M
9,800 sh across 2 lots
Exec Jun 29
Filed Jun 30 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $699K
4,376 sh × $159.65
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $255K
2,184 sh across 2 lots
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $108K
911 sh × $118.25
Exec Feb 10 2025
Filed Feb 12 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $191K
1,250 sh × $152.91
Exec Jan 31 2025
Filed Feb 4 2025 · 5:30 PM ET